Facebook Founder’s Science Group Hires AstraZeneca Board Memberby
Bargmann has been non-executive director since April 2015
Chan Zuckerberg Initiative chose Bargmann as science unit head
The Chan Zuckerberg Initiative, Facebook Inc. founder Mark Zuckerberg’s $3 billion effort to find cures for diseases, hired AstraZeneca Plc board member Cornelia Bargmann as president of its science arm.
Bargmann, an American neurobiologist, will step down as an Astra director effective Oct. 1. She served on the board committee that reviews the company’s chosen areas of research, and assesses its technology and the quality of its scientists. The science committee is also tasked with assessing research and experimental medicines the company may want to buy or license.
In her 18 months on the board of Cambridge, England-based Astra, Bargmann helped the drugmaker restock its pipeline as revenue from best-sellers declined. She is one of four women on the company’s 12-member board.
Bargmann is currently also head of the Lulu and Anthony Wang Laboratory of Neural Circuits and Behavior at The Rockefeller University in New York.